Skip to content

Clinical trials

Completed Lymphoma, T-Cell, Peripheral trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Status: Completed Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20121
20151
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affimed GmbH1
AstraZeneca1
Celgene1
Dizal Pharmaceuticals1
Millennium Pharmaceuticals, Inc.1
National Cancer Institute (NCI)1
Peter MacCallum Cancer Centre, Australia1
Therapeutic Advances in Childhood Leukemia Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral8
Recurrence4
Lymphoma, T-Cell, Cutaneous2
Hodgkin Disease1
Leukemia1
Lymphoma, T-Cell1
Mycosis Fungoides1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Sezary Syndrome1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.